EEG
AERI

E.E. Geduld’s Aerie Pharmaceuticals AERI Stock Holding History

E.E. Geduld’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$227K Hold
6,000
– – 0.13% 69
2016
Q3 		$226K Buy
+6,000
New +$132K 0.23% 85
2016
Q1 		– Sell
-16,000
Closed -$390K – 211
2015
Q4 		$390K Hold
16,000
– – 0.24% 47
2015
Q3 		$284K Hold
16,000
– – 0.27% 76
2015
Q2 		$282K Buy
+16,000
New +$293K 0.18% 129

Other funds holding AERI

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

E.E. Geduld's AERI Position: Q4 2016 in Review

E.E. Geduld held its Aerie Pharmaceuticals (AERI) position steady in Q4 2016 at 6,000 shares worth $227K. The position accounts for 0.13% of the portfolio, ranked #69.

E.E. Geduld first reported a position in AERI in Q2 2015 and has held it in 5 quarters since. The position peaked at $390K in Q4 2015. 151 funds tracked by Wall St. Rank hold AERI as of Q4 2016.

  • E.E. Geduld held 6,000 shares of Aerie Pharmaceuticals worth $227K as of Q4 2016.
  • E.E. Geduld left its Aerie Pharmaceuticals share count unchanged in Q4 2016.
  • Aerie Pharmaceuticals made up 0.13% of E.E. Geduld's portfolio in Q4 2016, its #69 holding.
  • E.E. Geduld first reported a position in Aerie Pharmaceuticals in Q2 2015 and has held it in 5 quarters since.
  • E.E. Geduld's Aerie Pharmaceuticals position peaked at $390K in Q4 2015.
  • 151 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2016.

Based on E.E. Geduld's 13F filing for Q4 2016, filed 8 Feb 2017.